NYSE: CATX - Perspective Therapeutics, Inc.

Altı ay boyunca karlılık: -80.26%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı Perspective Therapeutics, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında Perspective Therapeutics, Inc.

Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc.

daha fazla ayrıntı
and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2005-11-10
ISIN US46489V1044
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.perspectivetherapeutics.com
Цена ао 2.62
Günlük fiyat değişimi: -1.15% (2.62)
Haftalık fiyat değişimi: -0.7663% (2.61)
Aylık fiyat değişimi: -14.52% (3.03)
3 ayda fiyat değişimi: -25.57% (3.48)
Altı ayda fiyat değişimi: -80.26% (13.12)
Yıllık fiyat değişimi: +142.06% (1.07)
3 yılda fiyat değişimi: +640% (0.35)
5 yılda fiyat değişimi: +181.52% (0.92)
10 yılda fiyat değişimi: 0% (2.59)
Yılbaşından bu yana fiyat değişimi: -20.31% (3.25)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 133.02 1
P/BV 17.29 1
P/E 0 0
EV/EBITDA -62.27 0
Toplam: 0.875

Yeterlik

İsim Anlam Seviye
ROA, % -25.25 0
ROE, % -26.85 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.1163 10
Toplam: 9.6

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % -2.68 0
karlılık Ebitda, % 179.96 10
karlılık EPS, % 42.79 6
Toplam: 7.2
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Vanguard Group Inc 13213750 2.25
Baker Brothers Advisors, LLC 7639703 1.3
Blackrock Inc. 4538389 0.77
Geode Capital Management, LLC 2516649 0.43
Ghost Tree Capital, LLC 1600000 0.27
Osterweis Capital Management, Inc. 1582100 0.27
HighTower Advisors, LLC 1332238 0.23
Perkins Capital Management, Inc. 700000 0.12
State Street Corporation 671524 0.11
Taylor & Morgan Wealth Management, LLC 625000 0.11

ETF Paylaşmak, % Yıllık karlılık, % Temettüler, %
iShares Russell 2000 Growth ETF 0.04295 38.04 0.6026
iShares Morningstar Small-Cap Growth ETF 0.02697 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.02697 587.89 0.72598
iShares Morningstar Small-Cap ETF 0.01351 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.01351 391.25 1.60498
iShares Russell 3000 ETF 0.00132 24.83 1.43482



Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Johan M. Spoor CEO & Director 855.78k 1972 (53 yıl)
Mr. Jonathan R. Hunt CFO and Principal Financial & Accounting Officer 944.35k 1967 (58 yıllar)
Mr. Shane Cobb Executive Vice President of Operations N/A
Dr. Michael K. Schultz Ph.D. Chief Science Officer N/A
Mr. Andrew Bright Executive Vice President of Brachytherapy N/A
Dr. Markus Puhlmann M.B.A., M.D. Chief Medical Officer 633.14k 1966 (59 yıllar)
Mr. Amos Hedt BA, PGradDip Chief Business Strategy Officer N/A
Dr. Frances L. Johnson M.D. Chief Innovation Officer N/A
Mr. David Hauser Ph.D. Senior Vice President of Clinical Operations N/A
Steve Keefe Senior Vice President of Clinical Development

Adres: United States, Richland. WA, 350 Hills Street - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.perspectivetherapeutics.com